Elizabeth Shea | AbbVie, Inc. |
Richard A. Gonzalez | AbbVie, Inc. |
Michael E. Severino, M.D. | AbbVie, Inc. |
William J. Chase | AbbVie, Inc. |
Jeffrey Holford | Jefferies LLC |
Jami Rubin | Goldman Sachs & Co. LLC |
Joshua Schimmer | Evercore ISI |
Christopher Schott | JPMorgan Securities LLC |
Evan Seigerman | Barclays Capital, Inc. |
Steve Scala | Cowen and Co. LLC |
Geoffrey C. Porges | Leerink Partners LLC |
Vamil K. Divan | Credit Suisse Securities (NYSE:USA) LLC |
Gregory D. Fraser | Deutsche Bank Securities, Inc. |
Good morning and thank you all for holding. Welcome to the AbbVie third quarter 2017 earnings conference call. All participants will be able to listen only until the question-and-answer portion of this call. I would like to remind all parties today's call is being recorded.
If you have any objections, please disconnect at this time.